Processa Pharmaceuticals, Inc. Other Noncash Income
Processa Pharmaceuticals, Inc. (PCSA) reported Other Noncash Income of $47.59 thousand for the 27-month period ending 2013-06-30, per its 10-Q/A filed 2013-09-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncome · last filed 2013-09-06
- 2013-06-30: Other Noncash Income 6 month $47.59K; Other Noncash Income 27 month $47.59K.
| Period end | Other Noncash Income 6 month | Other Noncash Income 27 month |
|---|---|---|
| 2013-06-30 | $47.59K 10-Q/A · filed 2013-09-06 | $47.59K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |